These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27389028)

  • 1. Simulation of human plasma concentration-time profiles of the partial glucokinase activator PF-04937319 and its disproportionate N-demethylated metabolite using humanized chimeric mice and semi-physiological pharmacokinetic modeling.
    Kamimura H; Ito S; Chijiwa H; Okuzono T; Ishiguro T; Yamamoto Y; Nishinoaki S; Ninomiya SI; Mitsui M; Kalgutkar AS; Yamazaki H; Suemizu H
    Xenobiotica; 2017 May; 47(5):382-393. PubMed ID: 27389028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolites in safety testing assessment in early clinical development: a case study with a glucokinase activator.
    Sharma R; Litchfield J; Atkinson K; Eng H; Amin NB; Denney WS; Pettersen JC; Goosen TC; Di L; Lee E; Pfefferkorn JA; Dalvie DK; Kalgutkar AS
    Drug Metab Dispos; 2014 Nov; 42(11):1926-39. PubMed ID: 25142735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel Css-MRTpo approach to simulate oral plasma concentration-time profiles of the partial glucokinase activator PF-04937319 and its disproportionate N-demethylated metabolite in humans using chimeric mice with humanized livers.
    Kamimura H; Uehara S; Suemizu H
    Xenobiotica; 2020 Jul; 50(7):761-768. PubMed ID: 31721621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human plasma concentration-time profiles of troglitazone and troglitazone sulfate simulated by in vivo experiments with chimeric mice with humanized livers and semi-physiological pharmacokinetic modeling.
    Ito S; Kamimura H; Yamamoto Y; Chijiwa H; Okuzono T; Suemizu H; Yamazaki H
    Drug Metab Pharmacokinet; 2020 Dec; 35(6):505-514. PubMed ID: 32962912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of chimeric mice with humanized livers in new drug development: generation of pharmacokinetics, metabolism and toxicity data for selecting the final candidate compound.
    Kamimura H; Ito S
    Xenobiotica; 2016; 46(6):557-69. PubMed ID: 26444900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric mice with humanized liver.
    Katoh M; Tateno C; Yoshizato K; Yokoi T
    Toxicology; 2008 Apr; 246(1):9-17. PubMed ID: 18248870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologically Based Pharmacokinetic Modeling for Quantitative Prediction of Exposure to a Human Disproportionate Metabolite of the Selective Na
    Asano D; Nakamura K; Nishiya Y; Shiozawa H; Takakusa H; Shibayama T; Inoue SI; Shinozuka T; Hamada T; Yahara C; Watanabe N; Yoshinari K
    Drug Metab Dispos; 2023 Jan; 51(1):67-80. PubMed ID: 36273823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human urine and plasma concentrations of bisphenol A extrapolated from pharmacokinetics established in in vivo experiments with chimeric mice with humanized liver and semi-physiological pharmacokinetic modeling.
    Miyaguchi T; Suemizu H; Shimizu M; Shida S; Nishiyama S; Takano R; Murayama N; Yamazaki H
    Regul Toxicol Pharmacol; 2015 Jun; 72(1):71-6. PubMed ID: 25805149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450s in chimeric mice with humanized liver.
    Uehara S; Suemizu H; Yamazaki H
    Adv Pharmacol; 2022; 95():307-328. PubMed ID: 35953159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric mice transplanted with human hepatocytes as a model for prediction of human drug metabolism and pharmacokinetics.
    Sanoh S; Ohta S
    Biopharm Drug Dispos; 2014 Mar; 35(2):71-86. PubMed ID: 24114658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human plasma concentrations of cytochrome P450 probe cocktails extrapolated from pharmacokinetics in mice transplanted with human hepatocytes and from pharmacokinetics in common marmosets using physiologically based pharmacokinetic modeling.
    Utoh M; Suemizu H; Mitsui M; Kawano M; Toda A; Uehara S; Uno Y; Shimizu M; Sasaki E; Yamazaki H
    Xenobiotica; 2016 Dec; 46(12):1049-1055. PubMed ID: 26916082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of chimeric mice with humanized liver for study of human-specific drug metabolism.
    Bateman TJ; Reddy VG; Kakuni M; Morikawa Y; Kumar S
    Drug Metab Dispos; 2014 Jun; 42(6):1055-65. PubMed ID: 24700822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approach for in vivo protein binding of 5-n-butyl-pyrazolo[1,5-a]pyrimidine bioactivated in chimeric mice with humanized liver by two-dimensional electrophoresis with accelerator mass spectrometry.
    Yamazaki H; Kuribayashi S; Inoue T; Tateno C; Nishikura Y; Oofusa K; Harada D; Naito S; Horie T; Ohta S
    Chem Res Toxicol; 2010 Jan; 23(1):152-8. PubMed ID: 19928966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contribution of chimeric mice with a humanized liver to the evaluation of pharmacology, toxicity, and pharmacokinetics in drug discovery and development].
    Sanoh S; Ohta S
    Nihon Yakurigaku Zasshi; 2018; 151(5):213-220. PubMed ID: 29760366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of the accumulative human metabolite and human-specific glutathione conjugate of diclofenac in TK-NOG chimeric mice with humanized livers.
    Kamimura H; Ito S; Nozawa K; Nakamura S; Chijiwa H; Nagatsuka S; Kuronuma M; Ohnishi Y; Suemizu H; Ninomiya S
    Drug Metab Dispos; 2015 Mar; 43(3):309-16. PubMed ID: 25504502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of prediction of drug disposition and toxicity in humans using chimeric mice with humanized liver.
    Kitamura S; Sugihara K
    Xenobiotica; 2014 Jan; 44(2):123-34. PubMed ID: 24329499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the circulating metabolite profile of PF-04991532, a hepatoselective glucokinase activator, across preclinical species and humans: potential implications in metabolites in safety testing assessment.
    Sharma R; Litchfield J; Bergman A; Atkinson K; Kazierad D; Gustavson SM; Di L; Pfefferkorn JA; Kalgutkar AS
    Drug Metab Dispos; 2015 Feb; 43(2):190-8. PubMed ID: 25384899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric mice with humanized liver: Application in drug metabolism and pharmacokinetics studies for drug discovery.
    Naritomi Y; Sanoh S; Ohta S
    Drug Metab Pharmacokinet; 2018 Feb; 33(1):31-39. PubMed ID: 29183653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentrations of melengestrol acetate in humans extrapolated from the pharmacokinetics established in in vivo experiments with rats and chimeric mice with humanized liver and physiologically based pharmacokinetic modeling.
    Tsukada A; Suemizu H; Murayama N; Takano R; Shimizu M; Nakamura M; Yamazaki H
    Regul Toxicol Pharmacol; 2013 Apr; 65(3):316-24. PubMed ID: 23395687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of human pharmacokinetics of typical compounds by a physiologically based method using chimeric mice with humanized liver.
    Nakayama K; Ito S; Suzuki M; Takubo H; Yamazaki H; Nomura Y
    Xenobiotica; 2019 Apr; 49(4):404-414. PubMed ID: 29619871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.